Prostate Cancer - Results from #24800

Role of high dose rate brachytherapy in the treatment of prostate cancer - Abstract September 19, 2012

Tamoxifen for the management of breast events induced by non-steroidal antiandrogens in patients with prostate cancer: A systematic review - Abstract September 19, 2012

Impact of body mass index on perioperative morbidity, oncological, and functional outcomes after extraperitoneal laparoscopic radical prostatectomy - Abstract September 19, 2012

The evolving role of immunotherapy in prostate cancer - Abstract September 19, 2012

Study confirms erroneous link between prostate cancer and retrovirus from mice September 19, 2012

Researchers reveal underlying mechanism of powerful chemotherapy for prostate cancer treatment September 18, 2012

Obesity, prostate-specific antigen nadir, and biochemical recurrence after radical prostatectomy: Biology or technique? Results from the SEARCH database - Abstract September 18, 2012

Image-guided radiotherapy in prostate cancer: Concepts and implications - Abstract September 18, 2012

Low prostate-specific antigen and no Gleason score upgrade despite more extensive cancer during active surveillance predicts insignificant prostate cancer at radical prostatectomy - Abstract September 18, 2012

Improved overall survival trends of men with newly diagnosed M1 prostate cancer: A SWOG phase III trial experience (S8494, S8894 and S9346) - Abstract September 18, 2012

Is a visible (hypoechoic) lesion at biopsy an independent predictor of prostate cancer outcome? - Abstract September 18, 2012

Solid state TL detectors for in vivo dosimetry in brachytherapy - Abstract September 18, 2012

Local staging of prostate cancer: Comparative accuracy of T2-weighted endorectal MR imaging and transrectal ultrasound - Abstract September 18, 2012

Diagnostic accuracy of ultra-high-b-value 3.0-T diffusion-weighted MR imaging for detection of prostate cancer - Abstract September 18, 2012

5 Alpha-reductase inhibitors and prostate cancer: A statement of the Committee of Cancerology of the French Association of Urology - Abstract September 18, 2012

Biomarker-based targeting of the androgen-androgen receptor axis in advanced prostate cancer - Abstract September 18, 2012

Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: Final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study - Abstract September 18, 2012

Large urology group practice management: Reflections during Prostate Cancer Awareness Month September 17, 2012

The distribution of PSA age-specific profiles in healthy Irish men between 20 and 70 - Abstract September 17, 2012

Penile metastases of recurrent prostatic adenocarcinoma without PSA level increase: A case report - Abstract September 17, 2012

Page 1241 of 1437